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INTRODUCTION
Granulocytic sarcoma is an extramedullary collection of
myeloblasts. It was first described by Burns (1) in 1811, and
named ‘‘chloroma’’ by King (2) in 1853 because of its green
color, which is due to the presence of myeloperoxidase enzymes
in the immature myeloid cells. Rappaport first used the term
‘‘granulocytic sarcoma’’ in 1966 (3). This disease usually arises
during the course of acute myelogeneous leukemia, although
it also occurs infrequently in chronic myelogeneous leukemia
and other myeloproliferative disorders. The most common
sites of involvement are the periosteum, soft tissue, bone,
lymph nodes, and skin, but almost any site may be involved,
e.g., the brain, breasts, urinary bladder, and gastrointestinal
tract, and multiple organ involvement is also common (4).
However, isolated granulocytic sarcoma in the biliary tract
without evidence of leukemia is exceedingly rare.
Here, we describe a case of granulocytic sarcoma of the
proximal common bile duct, and right and left hepatic ducts
causing obstructive jaundice in a patient without evidence
of bone marrow disease; this was followed by acute myelo-
geneous leukemia with multilineage dysplasia.
CASE REPORT
A 30-yr-old man was admitted to our hospital because of
jaundice and mild fever with a chill. The patient had been
well until 3 months earlier, when he began to develop right
upper quadrant pain. One month before admission, the pain
worsened and at times radiated into his back. On admission,
a physical examination was unremarkable except for icteric
sclera. An abdominal examination revealed right upper quad-
rant tenderness but did not disclose hepatosplenomegaly or
a palpable mass. Laboratory tests on admission showed elevat-
ed total bilirubin (6.9 mg/dL; normal range 0-0.5), serum
aspartate aminotransferase (201  /L; normal range 0-40),
serum alanine aminotransferase (814 mg/dL; normal range
0-40), and alkaline phosphatase (158  /L; normal range 53-
128). Complete blood cell counts were within normal limits,
with no blast cells. Ultrasonography (US) revealed thickening
of the gallbladder wall and multiple tiny stones with some
sludge in the gallbladder. Endoscopic retrograde cholangio-
pancreatography (ERCP) revealed bile duct strictures (Fig. 1).
Endoscopic nasobiliary drainage (ENBD) was performed using
a 5-Fr. plastic stent. Abdominal computed tomography after
ENBD disclosed a low density rim around the ENBD tube,
but no definitive abnormal enhancing lesion of the wall or
mass was recognized (Fig. 2). The jaundice was temporally
relieved after ENBD and the patient received open cholecys-
tectomy under the impression of cholelithiasis with bile duct
stricture. The histologic diagnosis of the gallbladder was chro-
nic cholecystitis with cholelithiasis. Because jaundice had not
resolved after cholecystectomy, right lobectomy with hepati-
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Leukemia with Multilineage Dysplasia
: A Case Report and Literature Review
Granulocytic sarcoma is a rare extramedullary tumor composed of myeloid progenitor
cells. Primary involvement of the biliary tract without evidence of leukemia is exceed-
ingly rare. Here, we report an isolated biliary granulocytic sarcoma in a 30-yr-old
man who presented with jaundice, fever, and chill without any evidence of leukemia.
However, five months after the diagnosis, he developed acute myelogenous leu-
kemia with multilineage dysplasia and chromosomal abnormality. A rare possibility
of biliary granulocytic sarcoma should be considered as a differential diagnosis in
patients with obstructive jaundice. A histologic evaluation by aggressive diagnostic
intervention is important and may improve prognosis.
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cojejunostomy was performed. During the operation a diffuse
stricture from the middle common bile duct extending to
right and left hepatic ducts with wall thickening was observed.
A pathologic examination showed a monomorphous and dis-
cohesive infiltration of tumor cells along the bile duct wall
(Fig. 3A, B). Tumor cells were of medium size with large
nuclei showing dispersed chromatin, and one or more dis-
tinct but not prominent nucleoli. The cytoplasm was deeply
eosinophilic and granular reminiscent of metamyelocytes,
and indicative of myeloid differentiation (Fig. 3B). Immuno-
histochemistry showed positivity for myeloperoxidase (1:
20,000, Dako, Denmark) (Fig. 3C), CD34 (1:100, Dako, Den-
mark), and lysozyme (1:100, Zymed, New Zealand) but neg-
ativity for CD3 (1:200, Novocastra, U.K.) and CD20 (1:500,
Novocastra, U.K.). The liver was not involved by the tumor.
The histologic diagnosis was granulocytic sarcoma involving
the right and left hepatic ducts, superior bile duct, and cys-
tic duct. A bone marrow biopsy taken at the time was nor-
mal, and the patient had no symptoms or signs of leukemia.
The patient was then followed without other therapies such
as chemotherapy or radiotherapy. Five months after the ini-
tial diagnosis of granlocytic sarcoma, peripheral blood smear
showed normochromic normocytic anemia (Hb 11.4 g/dL,
Hct 33.1%) with aniso- and poikilo-cytosis, neutropenia
(3,700/ L) with 10% blasts, and thrombocytopenia (73,000/
L) with giant forms. Bone marrow aspiration and biopsy
showed leukemic blasts with abnormal nuclear folding, and
cytoplasmic blebs which were counted up to 40.1% of all
nucleated cells and infiltrated between normal and dyshema-
topoietic erythoid and myeloid cells (Fig. 4). Those blasts
were positive for myeloperoxidase, Sudan-black B, and per-
oxidase in cytochemical stain and expressed CD13, CD33,
myeloperoxidase, and CD34 in flow cytometric analysis.
Megakaryocytes with dysplasia were hardly observed in aspi-
ration smear but increased in number in biopsy. A diagnosis
of acute myelogeneous leukemia with multilineage dysplasia
was made according to the WHO classification or M2 by the
French-American-British (FAB) classification. A chromoso-
mal study showed 45,XY,del(3)(q21q27),-16,add (21)(q22)
[18]/46,XY[2]. The patient received induction chemother-
apy with idarubicin and cytarabine. A follow up bone mar-
row examination 21 days after the induction chemotherapy
showed persistent acute myelogenous leukemia (AML) with
multilineage dysplasia (Blasts: up to 4.3% of all nucleated
cells).
DISCUSSION
Granulocytic sarcoma usually occurs in one of the follow-
ing three clinical settings. The first is in patients with pre-
vious or current AML, and the second in patients as a sign
of blast transformation of CML or of some other chronic
myeloproliferative disorder. Third setting is in patients with
no other clinical evidence of hematologic disease at the time
of diagnosis. Neiman et al. (5) reported 61 patients with
granulocytic sarcoma, in which 48% of the cases were asso-
ciated with myeloproliferative disorder, 30% presented with
no overt leukemia, and 22% occurred as the initial presenta-
tion or during the course of AML. The most common sites
of involvement were the periosteum, soft tissue and bone
followed by the lymph nodes and skin, however it may be
Fig. 1. Endoscopic retrograde cholangiopancreatography (ERCP)
reveals the common bile duct stricture. 
Fig. 2. Computed tomogram discloses a low density rim around
the ENBD tube, but no definitive abnormal enhancing lesion or
mass is recognized. 552 C.O. Sung, Y.H. Ko, C.K. Park, et al.
found in any location including gingiva, pancreas, breast,
testis, spinal cord, or ovary (5-13).
Isolated biliary involvement by granulocytic sarcoma is
extremely rare. Only four cases of biliary granulocytic sarco-
ma have been reported in the English literature (Table 1).
The first case (14) was presented with a sign of AML relapse.
The patient received chemotherapy because of AML M2 and
reached complete remission. However, 29 months later, the
patient developed jaundice and abdominal pain, and was
diagnosed as having a granulocytic sarcoma in the common
bile duct. The second case (15) was of a 45-yr-old man who
underwent allogenic bone marrow transplantation (BMT)
because of chronic myelogeneous leukemia in blast crisis. On
day 69 after BMT, he presented with anorexia and jaundice
and was diagnosed as having a granulocytic sarcoma by open
biopsy. Third case (16) was of an 84-yr-old man presented
with jaundice. A CT scan showed a low-density mass at the
porta hepatis, and thickening of the gallbladder wall which
suggests gallbladder carcinoma. Endoscopic retrograde biliary
drainage was performed. Other therapies, such as laparotomy,
chemotherapy, and radiotherapy were not performed because
of old age. Fifty-one days after first admission, a peripheral
blood examination showed a white cell count of 16,400/ L
with 60% blast cells. A bone marrow examination revealed
AML (FAB type M0), and he died 1 month after diagnosis.
At autopsy, the suspected gallbladder carcinoma turned out
to be granulocytic sarcoma associated with AML. The forth
case (17) was of a 75-yr-old woman who presented with severe
obstructive jaundice. A bile duct carcinoma arising in the
hilum of the liver (a so-called Klatskin tumor) was clinically
Fig. 3. Microscopic finding of bile duct shows a monomorphous
and discohesive cellular infiltration along the bile duct wall (A) hav-
ing medium to large nuclei with one or more distinct but not promi-
nent nucleoli and a dispersed chromatin (H & E, ×40) (B). Tumor
cells are positive for myeloperoxidase (PAP, ×400) (C).
A
C
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suspected. A right hepatectomy was performed and revealed
a granulocytic sarcoma. Subsequently, a bone marrow biopsy
showed acute myelomonocytic leukaemia. The patient died
of disease 1 month after surgery. 
The present case also presented with abdominal pain and
jaundice. Likewise to the case reported by Matsueda et al.
(16), the patient had no preceding leukemia. Neiman et al.
(5) reported that among 15 patients of granulocytic sarcoma
without leukemia, 13 patients developed AML between 1 and
49 months (mean: 10.5 months) after diagnosis. Most non-
leukemic granulocytic sarcomas left untreated will progress
to acute nonlymphoblastic leukemia (ANLL), and patients
initially administered chemotherapy for ANLL showed longer
disease free intervals and overall survival (18-20). The pre-
sent patient did not receive chemotherapy until development
of leukemia, which may have caused the early development
of acute leukemia.
Granulocytic sarcoma occurs in only 2 to 8% of AML cases,
which are mainly of the M2 morphology, although the dis-
ease has also been associated with M3, M4, M5, and M7
morphologies (21). A patient having AML type M2 with
t(8;21) showed a greater tendency to develop granulocytic
sarcoma than others, as demonstrated by a study which found
that 4.5 to 38% of patients with t(8;21)(q22;q22) developed
granulocytic sarcoma (22, 23). The acute leukemia that devel-
oped in the current patient was FAB type M2 with chromo-
somal abnormality affecting chromosome 21(q22).
A diagnosis of biliary granulocytic sarcoma is difficult to
make by radiographic examination only, and is virtually im-
possible in a nonleukemic patient. Biliary granulocytic sar-
coma may be misdiagnosed as inflammatory lesion such as
cholangitis or cholecystitis or as a malignancy. Biliary gran-
ulocytic sarcoma reported previously, and the current case
commonly presented with obstructive jaundice with extrin-
sic bile duct compression. Therefore, biliary granulocytic
sarcoma should be included in the differential diagnosis of
Fig. 4. Bone marrow findings. Monomorphic myeloblasts in trephine biopsy (H & E, ×400) (A). Myeloblasts with cytoplasmic blebs and
dyshematopoietic erythroid cell (inset) (Wright stain, ×1,000) (B).
A B
Reference (year) Associated leukemia Involvement site Clinical feature Sex Age (yr)
N Engl J Med 47 M AML (FAB M2) Common bile duct Presentation as first sign of AML relapse
(1988) [14]
Rotter et al. 45 M CML Hepatic duct Presentation as a sign of CML relapse 
(1992) [15] after bone marrow transplantation
Matsueda et al. 84 M AML (FAB M0) Porta hepatis Isolated granulocytic sarcoma without
(1998) [16] evidence of leukemia 
Ascani et al. 75 W AML (FAB M4) Hepatic duct Granulocytic sarcoma with current leukemia
(2003) [17]
Our patient 30 M AML with multilineage  Superior bile duct  Isolated granulocytic sarcoma without
dysplasia (FAB M2) and hepatic duct evidence of leukemia
Table 1. Summary of biliary granulocytic sarcomas reported554 C.O. Sung, Y.H. Ko, C.K. Park, et al.
patients with obstructive jaundice. Early diagnostic interven-
tion with histologic evaluation is important, and may lead
to a better prognosis.
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